Skip to main content
. 2024 Oct 29;15:1370733. doi: 10.3389/fendo.2024.1370733

Table 4.

Mean serum melatonin levels (pg/mL) pre- and post-trial among diabetic patients with insomnia within treatment groups.

Serum melatonin level (pg/mL) T1 T2 T3 T4
Difference (mean ± SD) Pre-trial 7.03 ± 2.32 5.79 ± 2.43 6.26 ± 1.90 6.12 ± 2.25
Post-trial 6.84 ± 1.61 6.17 ± 2.07 6.50 ± 1.78 15.37 ± 17.37
p-value 0.502 0.047 0.189 0.001

T1: Placebo (starch tablets 250 mg × 2).

T2: Magnesium (250 mg × 2).

T3: Potassium (250 mg × 2).

T4: Magnesium + potassium (250 mg × 2).